# Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers

> **NCT02266550** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C] BILL 284 BS

## Key facts

- **NCT ID:** NCT02266550
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 1999-10
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2014-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02266550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02266550, "Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02266550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*